A team at the University of Alberta in Edmonton has reportedly made a breakthrough in the race to find a viable replacement for supply of technetium-99m (Tc-99m), a medical isotope produced by Canadas Chalk River reactor. The research has shown that Tc-99m can be created by a cyclotron.

A 4D PET imaging reconstruction technique may help improve image quality and reduce noise during cardiac-gated PET scans, according to research presented June 10 at the 59th annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in Miami.

The Agency for Healthcare Research and Quality (AHRQ) has released an e-prescribing toolkit for physician offices.

Hoping to increase the transparency of its decision-making processes, the Canadian FDA is developing guidance to clarify what factors it takes into account when determining whether a regulated medical product is to be considered a device rather than a drug, and vice versa.

MIAMIRadium-223 chloride radioisotope therapy, a new approach to the treatment of bone metastases, boosted survival, delayed complications and was well-tolerated, according to an interim analysis of the ALSYMPCA trial presented at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). This represents a real breakthrough in the management of late-stage prostate cancer, said Valerie Lewington, BM, MSc, professor of clinical therapeutic nuclear medicine at Kings College in London.

The Society of Nuclear Medicine (SNM) membership voted June 11 for the proposal to change the name of the organization to the Society of Nuclear Medicine and Molecular Imaging (SNMMI). In an official vote held at the business meeting portion of the SNMMI 2012 annual meeting in Miami, more than two-thirds of society members present voted affirmatively on the name change.

MIAMIA skin patch containing phosphorus-32 destroyed basal cell carcinoma in 80 percent of patients, according to a small study presented June 11 at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). The novel treatment may open new doors in therapeutic nuclear medicine and lead to a new treatment standard for basal cell carcinoma, said Rakesh Kumar, MD, PhD, of the All India Institute of Medical Sciences in New Delhi.

 MIAMIThe current U.S. political arena is characterized by dichotomy. Most pundits, Beltway insiders and ordinary citizens agree there will be both political stagnation and little change in the next six to 18 months. Despite the uncertainty about what lies ahead, some broad predictions about healthcare are likely to withstand the shuffle, Brian P. Carey, Esq, partner at Foley Hoag in Washington D.C., said during the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).